Combined effects of synbiotic and sitagliptin versus sitagliptin alone in patients with nonalcoholic fatty liver disease
OPEN Clinical and molecular hepatology | 13 Jun 2018
S Sayari, H Neishaboori and M Jameshorani
Non-alcoholic fatty liver disease (NAFLD) is one of the most prevalent chronic liver diseases in recent years. The aim of this study was to evaluate the effects of sitagliptin with and without a synbiotic supplement in the treatment of patients with NAFLD.
* Data courtesy of Altmetric.com